Factors Predicting the Health Status of Women with Ovarian Cancer During Five Treatment Phases.

[1]  A. Szymańska-Chabowska,et al.  Physical Activity and Cancer Care—A Review , 2022, Cancers.

[2]  Henok Biresaw,et al.  Sleep Quality and Associated Factors Among Adult Cancer Patients Under Treatment at Oncology Units in Amhara Region, Ethiopia , 2022, Nature and science of sleep.

[3]  Tanuma Mistry,et al.  Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India , 2022, Supportive Care in Cancer.

[4]  D. Riemann,et al.  Insomnia and circadian sleep disorders in ovarian cancer: Evaluation and management of underestimated modifiable factors potentially contributing to morbidity , 2021, Journal of sleep research.

[5]  V. Chen,et al.  Sleep Quality and Related Factors in Patients with Breast Cancer: A Cross-Sectional Study in Taiwan , 2021, Cancer management and research.

[6]  M. R. Yaznil,et al.  Quality of life among ovarian cancer survivors in Haji Adam Malik General Hospital Medan, Indonesia , 2020, Health Science Journal of Indonesia.

[7]  G. Jayson,et al.  Psychosexual morbidity in women with ovarian cancer , 2020, International Journal of Gynecological Cancer.

[8]  G. Scambia,et al.  Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) , 2020, International Journal of Gynecological Cancer.

[9]  C. Coltman,et al.  What are the Barriers and Enablers to Physical Activity Participation in Women with Ovarian Cancer? A Rapid Review of the Literature. , 2020, Seminars in oncology nursing.

[10]  A. deFazio,et al.  Insomnia and its association with quality of life in women with ovarian cancer. , 2020, Gynecologic oncology.

[11]  Ali Montazeri,et al.  Quality of Life in Patients with Gynecological Cancers: A Web-Based Study , 2020, Asian Pacific journal of cancer prevention : APJCP.

[12]  A. Okamoto,et al.  Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial. , 2020, European journal of cancer.

[13]  R. Basha,et al.  Ovarian cancer: Current status and strategies for improving therapeutic outcomes , 2019, Cancer medicine.

[14]  L. Brotto,et al.  Sexual Function, Quality of Life, and Experiences of Women with Ovarian Cancer: A Mixed-Methods Study , 2019, Sexual medicine.

[15]  S. Lockwood,et al.  Ovarian Cancer: An Integrated Review. , 2019, Seminars in oncology nursing.

[16]  B. Arkan,et al.  Determination of Compassion Levels of Nurses Working at a University Hospital , 2019, Journal of Religion and Health.

[17]  R. Edwards,et al.  Diagnosis and Treatment of Ovarian Cancer. , 2018, Hematology/oncology clinics of North America.

[18]  A. Michalsen,et al.  The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study , 2018, BMC cancer.

[19]  W. Chie,et al.  Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients , 2018, BMC Cancer.

[20]  M. Lai,et al.  Prognostic factors in epithelial ovarian cancer: A population-based study , 2018, PloS one.

[21]  R. Delorme,et al.  Insomnia and hypersomnia in major depressive episode: Prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study. , 2018, Journal of affective disorders.

[22]  E. Funkhouser,et al.  Values and worries of ovarian cancer patients. , 2017, Gynecologic oncology.

[23]  J. Nho,et al.  Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. , 2017, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[24]  Q. Wen,et al.  Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[25]  Q. Wen,et al.  Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer , 2017, Health and Quality of Life Outcomes.

[26]  K. Baggerly,et al.  Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach. , 2017, Gynecologic oncology.

[27]  N. Colombo,et al.  Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future , 2017, International Journal of Gynecologic Cancer.

[28]  N. Ezendam,et al.  Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry. , 2016, Current oncology.

[29]  M. Irwin,et al.  Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors - I. , 2016, Gynecologic oncology.

[30]  M. Ebell,et al.  A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer. , 2016, American journal of preventive medicine.

[31]  S. Pignata,et al.  Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group. , 2016, Gynecologic oncology.

[32]  D. Ahmed-Lecheheb,et al.  Ovarian cancer survivors’ quality of life: a systematic review , 2016, Journal of Cancer Survivorship.

[33]  D. Alberts,et al.  Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study. , 2015, Gynecologic oncology.

[34]  H. Kitchener,et al.  Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial , 2015, The Lancet.

[35]  C. Aghajanian,et al.  A systematic review of ovarian cancer and fear of recurrence , 2015, Palliative and Supportive Care.

[36]  W. Chie,et al.  Conceptual structure of the Taiwan Chinese version of the EORTC QLQ-C30 , 2015, Quality of Life Research.

[37]  M. C. Vos,et al.  Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. , 2014, Gynecologic oncology.

[38]  S. Kalloger,et al.  Determinants of quality of life in ovarian cancer survivors: a pilot study. , 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[39]  M. Stockler,et al.  Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. , 2013, The oncologist.

[40]  F. Penedo,et al.  Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis , 2013, Cancer.

[41]  K. Gil,et al.  The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study. , 2012, Gynecologic oncology.

[42]  E. Petru,et al.  Prospective assessment of quality of life in long‐term ovarian cancer survivors , 2011, International journal of cancer.

[43]  A. Fader,et al.  A review of issues surrounding quality of life among women with ovarian cancer. , 2010, Gynecologic oncology.

[44]  N. Beji,et al.  Quality of life and sexual functioning in gynecological cancer patients: results from quantitative and qualitative data. , 2010, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[45]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[46]  W. Chie,et al.  Quality of life of patients with ovarian cancer in Taiwan: validation and application of the Taiwan Chinese version of the EORTC QLQ‐OV28 , 2009 .

[47]  Hang Lee,et al.  Comparison of the quality of life of early and advanced stage ovarian cancer survivors. , 2009, Gynecologic oncology.

[48]  D. Bodurka,et al.  Survivors of gynecologic malignancies: impact of treatment on health and well-being , 2008, Journal of Cancer Survivorship.

[49]  E. Jenison,et al.  Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery , 2007, Health and quality of life outcomes.

[50]  B. Ferrell,et al.  Perspectives on the impact of ovarian cancer: women's views of quality of life. , 2005, Oncology nursing forum.

[51]  David Cella,et al.  Quality of life in ovarian cancer. , 2005, The Journal of reproductive medicine.

[52]  D. Osoba,et al.  Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  W. Chie,et al.  Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13 , 2004, Quality of Life Research.

[54]  Chiun-Sheng Huang,et al.  Quality of life of breast cancer patients in Taiwan: Validation of the Taiwan Chinese version of the EORTC QLQ‐C30 and EORTC QLQ‐BR23 , 2003, Psycho-oncology.

[55]  T. Bauknecht,et al.  A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. , 2003, Journal of the National Cancer Institute.

[56]  P. Fayers,et al.  Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. , 2002, European journal of cancer.

[57]  M. Atkinson,et al.  Quality of life in ovarian cancer patients receiving chemotherapy. , 2001, Gynecologic oncology.

[58]  H. V. van Houwelingen,et al.  Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  C. Wild,et al.  Vector Generalized Additive Models , 1996 .

[60]  C. Friedenreich,et al.  Effects of exercise dose and type during breast cancer chemotherapy on longer‐term patient‐reported outcomes and health‐related fitness: A randomized controlled trial , 2019, International journal of cancer.